US Patent Issued to ANAVEX LIFE SCIENCES on Feb. 24 for "ANAVEX2-73 for the treatment of genetic neurodevelopmental disorders" (New York Inventors)

ALEXANDRIA, Va., Feb. 24 -- United States Patent no. 12,558,340, issued on Feb. 24, was assigned to ANAVEX LIFE SCIENCES CORP. (New York).

"ANAVEX2-73 for the treatment of genetic neurodevelopmental disorders" was invented by Christopher U. Missling (New York) and Alani Selvey (New York).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides methods for treating a genetic neurodevelopmental disorder, such as Rett syndrome or Fragile X-syndrome, comprising evaluating a subject for his/her occurrence and/or severity of symptoms and/or specific biomarker levels before administering a dosage formulation of ANAVEX2-73 to the subject, administering the dosage formulation of ANAVEX2-73 to the ...